Emerging role of US healthcare data in global health technology assessment: a multistakeholder perspective

30 May 2023

Written by ASHLEY JAKSA (AETION), Karen Facey (University of Edinburgh), Joshua Ray (Roche), Laurie Lambert (CADTH)

Events coverage Health economics Health policy Health technology assessment Interviews ISPOR Real-world evidence

Whilst randomized controlled trials (RCTs) remain the gold-standard for decision making in healthcare, in some cases they do not provide all the information that is important for health technology assessment (HTA) bodies and payers. Real-world data (RWD) sources offer the potential to fill these evidence gaps but the quality of this data is key. RWD collected in the US could be a solution but transferring this data and the resulting real-world evidence (RWE) between jurisdictions can be challenging. In this interview, Karen Facey (University of Edinburgh, UK; RWE4Decisions Facilitator), Laurie Lambert (Canadian Agency for Drugs and Technologies in Health [CADTH],...